
Israel’s Competition Authority announced on Tuesday, May 11, that it was considering imposing a fine of about 6 million shekels (US$1.8 million) on Facebook for buying two Israeli companies without the agency’s consent.
The authority stated it sent a hearing letter to Facebook after it found the social media giant purchased two Israeli companies, RedKix in 2018 and Service Friend in 2019, without approval and contrary to Israel’s Economic Competition Law.
“Facebook was obliged to report the transactions required the director general’s consent since Facebook is a ‘monopolist’, whose market share in Israel exceeds 50%,” the authority stated.
It stated the fine is subject to a hearing and Facebook has the right to submit its arguments to the authority’s director general within 60 days, reported CNBC.
Under the law, an entity which holds 50% or more in any relevant market is required to obtain the director general’s consent before making any transaction that constitutes a “merger of companies,” it noted.
The authority said Facebook, together with Instagram, is considered a monopoly in the market of social networks in Israel.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas